← All trials
NCT00514891
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2007
- Primary completion
- Jun 1, 2012
- Completion date
- Dec 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 9500
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Bandim Health ProjectLead sponsor
- Statens Serum InstitutOverall official - principal investigator
- Government of Guinea-BissauCollaborator
- Aarhus UniversityCollaborator
- Bandim Health ProjectStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.